We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,
Australasia,Asia,Middle East,Africa
Monthly Production Capacity: hundreds of grams
Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag
Delivery Lead Time: In stock or 2-3 weeks
Sample Provided: yes
Payment Terms: T/T
As μ-Conotoxin GIIIB composed of 22 amino acids, since the sequence contains three pairs of disulfide bonds, μ-Conotoxin GIIIB has the characteristics of stable secondary structure and high activity. And μ-Conotoxin GIIIB can specifically act on acetylcholine receptors and various receptor subtypes of other neurotransmitters, as well as various ion channels such as calcium, sodium, and potassium. It can not only be directly used as a drug, but also as an ideal Molecular templates are used to develop lead compounds for new drugs and are also of great significance to the study of neurobiology. In terms of peptide synthesis, μ-Conotoxin GIIIB has a certain degree of difficulty, especially the ring formation process, which requires a reasonable process. Go Top Peptide Biotech has mature process of μ-Conotoxin GIIIB.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
